Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-01-15
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if adding a medication called dexmedetomidine to an epidural block works better than a standard epidural to control pain in women undergoing gynecologic laparotomy (abdominal surgery). The main questions it aims to answer are:
Does adding dexmedetomidine reduce pain scores and the need for extra pain medicine in the first 24 hours after surgery? Does it lower inflammation levels and reduce the risk of developing chronic pain 3 months later?
Participants will receive an epidural (pain medicine delivered through a small tube in the back) combined with general anesthesia for their surgery. Researchers will compare two groups:
One group will receive the standard epidural medicine (bupivacaine) mixed with dexmedetomidine.
The other group will receive the standard epidural medicine (bupivacaine) alone.
Researchers will measure the participants' pain levels, how much pain medicine they use, and blood markers for inflammation for 24 hours after surgery. They will also contact participants 3 months later to check for any long-term pain.